COVID-19 UPDATE

Contact

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

Events & Presentations

Past Events

BDSI Second Quarter 2020 Financial Results Call and Webcast

Aug 5, 2020 at 8:30 AM EDT

Listen to webcast

Supporting Materials

View Presentation 662.8 KB

William Blair 40th Annual Growth Stock Conference

Jun 11, 2020 at 9:40 AM EDT

Listen to webcast

Jefferies Virtual Healthcare Conference

Jun 2, 2020 at 3:00 PM EDT

Listen to webcast

Supporting Materials

View Presentation 1.3 MB

BDSI First Quarter 2020 Financial Results Call and Webcast

May 7, 2020 at 4:30 PM EDT

Listen to webcast

Supporting Materials

View Presentation 586.1 KB

BDSI Fourth Quarter 2019 Financial Results Call and Webcast

Mar 12, 2020 at 4:30 PM EDT

Listen to webcast

Supporting Materials

View Presentation 603.9 KB

Piper Jaffray 31st Annual Healthcare Conference

Dec 4, 2019 at 12:00 PM EST

Jefferies Global Healthcare Conference

Nov 20, 2019 at 5:20 PM GMT

Listen to webcast

Supporting Materials

View Presentation 1.4 MB

BDSI Third Quarter 2019 Financial Results Call and Webcast

Nov 12, 2019 at 4:30 PM EST

Listen to webcast

Supporting Materials

View Presentation 11 MB

Cantor Fitzgerald 2019 Healthcare Conference

Oct 3, 2019 at 1:15 PM EDT

Listen to webcast

Recent BDSI News

BioDelivery Sciences Reports Strong Q2 2020 Results August 5, 2020

Second Quarter Total Company Net Revenue Increased 23% versus Prior Year to $36.6 Million Second Quarter BELBUCA® Net Sales Increased 34% versus Prior Year to $32.3 Million BELBUCA and Symproic® Each Reach All Time High TRx Volume and Market Share Conference Call and Webcast Scheduled for 8:30 AM ...

BioDelivery Sciences to Report Second Quarter 2020 Financial Results on August 5, 2020 July 27, 2020

RALEIGH, N.C. , July 27, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its second quarter 2020 ...

BioDelivery Sciences to Present at Two Upcoming Investor Conferences May 29, 2020

RALEIGH, N.C. , May 29, 2020 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey , Interim Chief Executive ...

More news

More events

Stay Connected

Stay up to date on the latest news

Get started now